Missouri Cures Education Foundation and Mid-America Transplant are proud to present a Regenerative Medicine Symposium on October 11, 2018, from 5:00 PM to 7:00 PM at Mid-America Transplant. This event is free to attend. However, space is limited and pre-registration is required. 5:00-6:00 PM Registration and cocktail reception 6:00-7:00 PM Special Presentations: PRESENTING: Dr. Farshid Guilak
Over 650,000 Americans suffer from end-stage kidney disease - a life-threatening condition caused by the loss of kidney function. The best available treatment for these patients is a kidney transplant from a genetically matched, living donor. However, patients who receive a transplant must take life-long immunosuppressive drugs to prevent their immune system from rejecting the
Retinal pigment epithelial (RPE) cells derived from human embryonic stem cells can be safely transplanted into the eyes of patients with retinal degeneration, with early signs of vision gain, according to pioneers in the field. Two teams of researchers reported preliminary findings from phase 1 and phase 2 trials at the American Academy of Ophthalmology (AAO)
Monday, July 11, 2011 By: Keio University School of Medicine, Tokyo A study published in the current issue of Cell Transplantation (20:5) investigating optimal routes for transplanting neural stem/progenitor cells (NS/PCs) in animal models of spinal cord injury (SCI) has demonstrated that intralesional (IL) injection conferred benefits over intravenous injection (IV) and intrathecal (IT) injection.
Friday, December 10, 2010 By: Medical News Today Some adults and children with acute leukemia could benefit from certain transplants of blood stem cells, but the benefits are not equal across all cases of leukemia, according to a new review of 15 studies. Acute leukemias classified as either acute myeloid leukemia (AML) or acute lymphoblastic